We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Morphotek Divests Cell Evolution Service Business to Invitrogen

News   Jan 12, 2006

 
Morphotek Divests Cell Evolution Service Business to Invitrogen
 
 
 

RELATED ARTICLES

Obesity and Cancer: ‘Fat-clogged’ Immune Cells Fail to Fight Tumors

News

Researchers have gained a new understanding of the link between obesity and cancer. In the presence of excess fat, the immune surveillance system fails due to an obesity-fueled lipid accumulation in natural killer (NK) cells, preventing their cellular metabolism and trafficking.

READ MORE

$3.6 Million to Study Adverse Effects of Genome Editing

News

As genome editing technologies advance toward clinical therapies, they are raising hopes of a completely new way to treat disease. However, challenges need to be addressed before potential treatments can be widely used in patients. To tackle these challenges, the National Institutes of Health has launched the Somatic Cell Genome Editing program, which has awarded multiple grants including more than $3.6 million to assess the safety of genome editing in human cells and tissues.

READ MORE

Paving the Way to Regulate Out of Control Immune Responses

News

A potential new pathway has been found to regulate immune response and control inflammatory diseases of the central nervous system such as meningitis and sepsis.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE